MedTrace Logo

Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)

NCT03779490 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-04-06

No results posted yet for this study

Summary

The purpose of the study is to assess the safety and the effectiveness of the Cardioband Tricuspid Reconstruction System.

Conditions

  • Tricuspid Regurgitation
  • Tricuspid Insufficiency

Interventions

DEVICE

Transcatheter Tricuspid Valve Repair

Transcatheter Tricuspid Valve Repair with Edwards Cardioband TR

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Georg Nickenig, MD · Universitätsklinikum Bonn, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-24
Primary Completion
2022-09-30
Completion
2027-12-31

Countries

  • Germany
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03779490 on ClinicalTrials.gov